'Metastatic colorectal cancer patients' presentation slideshows

Disclosure: Gianluca Masi

A randomized study evaluating the continuation of bevacizumab beyond progression in metastatic colorectal cancer patients who received bevacizumab as part of first-line treatment: results of the BEBYP trial by the Gruppo Oncologico Nord Ovest (GONO).

449 views • 22 slides

PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors

397 views • 15 slides

Background and Specific Aims

Response rate using conventional criteria is a poor surrogate for clinical benefit on progression-free (PFS) and overall survival (OS) in metastatic colorectal cancer (mCRC): A comparative analysis of N9741 and AVF2107.

283 views • 10 slides

Introduction

K-RAS mutation status associated with clinical outcome in metastatic colorectal cancer patients treated with 5-fluorouracil/oxaliplatin

103 views • 1 slides